Impact of Metastasis-directed Therapy Guided by Different PET/CT Radiotracers on Distant and Local Disease Control in Oligorecurrent Hormone-sensitive Prostate Cancer: A Secondary Analysis of the PRECISE-MDT Study
Radiology: Imaging Cancer · 2025
DOI: 10.1148/rycan.240150 ↗Kurz gefasst
Fachartikel in der Zeitschrift Radiology: Imaging Cancer, 2025. Verfasst von Francesco Lanfranchi und 40 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Positron Emission Tomography Computed Tomography, Radiopharmaceuticals, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: European Union–NextGenerationEU.
Abstract (Originalsprache)
Metastasis-directed therapy guided by gallium 68 ( 68 Ga) prostate-specific membrane antigen (PSMA)-11 PET/CT improved metastasis-free survival but not local recurrence-free survival compared with fluorine 18 ( 18 F)-PSMA-1007 and 18 F-fluorocholine PET/CT in patients with nodal or bone oligorecurrent prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
- Department of Radiotherapy, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
- Department of Nuclear Medicine, ASST Spedali Civili di Brescia, University of Brescia, Brescia, Italy.
- Department of Radiation Oncology, ASST Spedali Civili di Brescia, University of Brescia, Brescia, Italy.
- Department of Nuclear Medicine, Careggi University Hospital, Florence, Italy.
- Nuclear Medicine, Oncological Medical and Specialist Department, University Hospital of Ferrara, Ferrara, Italy.
ORCID-Profile: Francesco Lanfranchi, Serena Grimaldi, Matteo Salgarello
Förderung
- European Union–NextGenerationEU
Zitieren
APA
Lanfranchi, F., Belgioia, L., Albano, D., Triggiani, L., Linguanti, F., Urso, L., Mazzola, R., Rizzo, A., D'Angelo, E., Dondi, F., Mataj, E., Pedersoli, G., Abenavoli, E. M., Vaggelli, L., Detti, B., Ortolan, N., Malorgio, A., Guarneri, A., Garrou, F., …, & Bauckneht, M. (2025). Impact of Metastasis-directed Therapy Guided by Different PET/CT Radiotracers on Distant and Local Disease Control in Oligorecurrent Hormone-sensitive Prostate Cancer: A Secondary Analysis of the PRECISE-MDT Study. Radiology: Imaging Cancer. https://doi.org/10.1148/rycan.240150
Vancouver
Lanfranchi F, Belgioia L, Albano D, Triggiani L, Linguanti F, Urso L, et al. Impact of Metastasis-directed Therapy Guided by Different PET/CT Radiotracers on Distant and Local Disease Control in Oligorecurrent Hormone-sensitive Prostate Cancer: A Secondary Analysis of the PRECISE-MDT Study. Radiology: Imaging Cancer. 2025. doi:10.1148/rycan.240150
BibTeX
@article{Lanfranchi2025,
author = {Lanfranchi, Francesco and Belgioia, Liliana and Albano, Domenico and Triggiani, Luca and Linguanti, Flavia and Urso, Luca and Mazzola, Rosario and Rizzo, Alessio and D'Angelo, Elisa and Dondi, Francesco and Mataj, Eneida and Pedersoli, Gloria and Abenavoli, Elisabetta Maria and Vaggelli, Luca and Detti, Beatrice and Ortolan, Naima and Malorgio, Antonio and Guarneri, Alessia and Garrou, Federico and Fiorini, Matilde and Grimaldi, Serena and Ghedini, Pietro and Iorio, Giuseppe Carlo and Iudicello, Antonella and Rovera, Guido and Fornarini, Giuseppe and Bongiovanni, Diego and Marcenaro, Michela and Pazienza, Filippo Maria and Timon, Giorgia and Salgarello, Matteo and Racca, Manuela and Bartolomei, Mirco and Panareo, Stefano and Ricardi, Umberto and Bertagna, Francesco and Alongi, Filippo and Barra, Salvina and Morbelli, Silvia and Sambuceti, Gianmario and Bauckneht, Matteo},
title = {Impact of Metastasis-directed Therapy Guided by Different PET/CT Radiotracers on Distant and Local Disease Control in Oligorecurrent Hormone-sensitive Prostate Cancer: A Secondary Analysis of the PRECISE-MDT Study},
journal = {Radiology: Imaging Cancer},
year = {2025},
doi = {10.1148/rycan.240150}
}
EUVIMED